Cargando…
Post-tuberculous lung disease: should we be using Theophylline?
Tuberculosis affects 10 million people and over 320,000 South Africans every year. A significant proportion of patients treated for tuberculosis develop post-tuberculous lung disease (PTBLD), a disease of chronic respiratory impairment for which there is a lack of affordable treatment options. PTBLD...
Autores principales: | Karamchand, Sumanth, Williams, Morne, Naidoo, Poobalan, Decloedt, Eric, Allwood, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947523/ https://www.ncbi.nlm.nih.gov/pubmed/33717595 http://dx.doi.org/10.21037/jtd-20-1298 |
Ejemplares similares
-
Access to novel anti-diabetic agents in resource limited settings: A brief commentary
por: Naidoo, Poobalan, et al.
Publicado: (2023) -
Real-world evidence and product development: Opportunities, challenges and risk mitigation
por: Naidoo, Poobalan, et al.
Publicado: (2021) -
Management of adult patients with type 1 diabetes mellitus in Africa: A post-hoc cohort analysis of 12 African countries participating in the International Diabetes Management Practices Study (Wave 7)
por: Mbanya, Jean Claude, et al.
Publicado: (2020) -
Theophylline
por: Barnes, Peter J.
Publicado: (2010) -
Management of intracranial tuberculous mass lesions: how long should we treat for?
por: Marais, Suzaan, et al.
Publicado: (2020)